|
|
|
COVER STORY
In searching 400 years of French-Canadian history for genetic clues to diseases among Quebec's founding population, Genizon BioSciences — formerly Galileo Genomics — is rapidly becoming the bio-IT company du jour.
STRATEGIC INSIGHTS
| Business+Strategy |
IT+Informatics |
DEAL FLOW · Biotechs learn to squeeze value out of hot product deals when choosing a suitor.
GUEST COMMENTARY · Lessons for successfully guiding the 21st-century revolution in bioscience.
Insights | Outlook · Budgeting and measuring the success of compliance initiatives is a credibility issue for CIOs.
|
HIGH-PERFORMANCE COMPUTING · The desktop computing giant plans a big push into life science clusters.
ADAPTIVE SELECTION · An accelerated mutation rate produced humans' large brain, according to a study.
RESEARCH TOOLS · More than 700 'open' molecular biology databases are now available from around the world.
INSIDE THE BOX · Does it make sense to rent CPU hours instead of acquiring computers?
|
| Science+Technology |
In Every Issue |
DISCOVERY TOOLS · Columbia's SLIMS picks an old drug for a new disease.
LAB TECHNIQUES · A new turnkey system includes a software suite to speed throughput and smooth logistics.
LAB TECHNIQUES · Fluorescent proteins for a new palette (or palate).
FULLY EQUIPPED · In vitro diagnostic microarrays are an important tool in oncology.
|
First Base | The task of retrieving and identifying bodies in Southeast Asia enters a new phase.
By Kevin Davies
The Russell Transcript | Turning the Senate majority leader's healthcare vision into reality will be quite a challenge.
By John Russell
|
|
|
|
|